CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

CYANOTECH CORP

Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 10, 2025

$0.70+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $5.11M
P/E (TTM): –
Dividend yield: –

CYANOTECH CORP income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31	FY 2010 2010-03-31
Revenue	24	23	23	36	32	32	30	34	32	32	34	28	27	25	17	16
Cost of Revenue	17	17	16	22	21	19	20	21	20	20	19	17	17	15	10	9.11
Gross Profit	6.88	5.95	7.26	14	11	13	10	13	12	12	14	11	11	9.77	6.34	6.63
Research & Development	0.45	0.69	0.77	0.71	0.64	0.61	0.92	0.56	0.59	0.63	0.52	0.47	0.26	0.32	0.28	0.26
Selling, General & Admin	8.94	9.85	9.41	10	10	11	13	11	12	12	14	11	8.36	6.49	4.81	4.71
Selling & Marketing	4.54	5.38	4.75	4.91	5.52	5.76	6.82	6.44	6.26	6.22	5.67	4.47	3.68	2.48	1.99	1.40
General & Administrative	4.40	4.46	4.66	5.37	4.88	5.28	5.72	4.96	6.05	5.80	7.96	6.42	4.68	4.01	2.82	3.31
Advertising Expenses	1.12	1.31	1.51	1.46	2.12	1.99	2.41	1.55	0.81	0.94	1.08	1.13	0.58	0.32	0.28	–
Operating Expenses	9.38	11	10	11	11	12	13	12	13	13	14	11	8.66	6.87	5.11	5.13
Operating Income	-2.51	-4.59	-2.92	2.57	0.08	1.05	-3.00	1.41	-0.68	-0.79	0.32	-0.21	2.23	2.90	1.23	1.50
Interest Expense	0.69	0.67	0.50	0.39	0.55	0.66	0.58	0.50	–	–	–	–	–	–	–	–
Other Non-Operating Income	–	–	-0.50	-0.39	0.84	-0.66	-0.58	-0.50	-0.53	-0.28	-0.09	-0.12	-0.11	-0.05	-0.07	-0.09
Asset Impairment Charges	0.01	0	0.01	0.02	0.06	0	0	0	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	-0.11	-0.06	-0.01	-0.10	-0.05	-0.05	-0.06	-0.02	-0.16
Pretax Income	-3.20	-5.26	-3.42	2.18	0.92	0.40	-3.58	0.92	-1.21	-1.07	0.23	-0.33	2.11	2.85	1.16	1.42
Income Tax Expense	0.01	0.01	0.02	0.03	0.00	0.01	0.02	-0.11	0.01	3.33	0.25	0.09	-2.05	-0.78	-0.57	0.02
Net Income	-3.20	-5.27	-3.44	2.15	0.92	0.39	-3.60	1.03	-1.22	-4.40	-0.02	-0.42	–	–	–	–
Net Income to Common	–	–	–	–	–	–	–	–	–	–	-0.02	-0.42	4.16	3.63	1.73	1.39
EPS (Basic)(per share)	-0.45	-0.81	-0.55	0.35	0.15	0.06	-0.62	0.18	-0.21	-0.79	0.00	-0.08	0.76	0.67	0.32	0.26
EPS (Diluted)(per share)	–	-0.81	-0.55	0.35	0.15	0.06	-0.62	0.18	-0.21	-0.79	0.00	-0.08	0.74	0.66	0.32	0.26
Shares Outstanding (Basic, Weighted)(shares)	7.07	6.53	0.01	0.01	6.07	5.96	5.82	5.71	5.66	5.58	5.52	5.48	5.46	5.41	5.35	5.25
Shares Outstanding (Diluted, Weighted)(shares)	7.07	0.01	0.01	0.01	6.08	5.96	5.82	5.78	5.66	5.58	5.52	5.48	5.66	5.53	5.41	5.35
EBITDA	-1.03	-3.00	-1.27	4.17	1.83	2.99	-1.09	3.29	1.30	0.74	1.57	0.88	3.07	3.60	1.85	2.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2025

Profitability, TTM

Gross margin: 32.0%
Operating margin: -4.2%
Net margin: -7.0%
Return on equity, FY2025: -30.9%

Financial strength

Current ratio: 1.00
Debt to equity: 1.04
Debt to assets: 34.8%
Cash to current liabilities: 5.5%

Valuation

P/E ratio: –
Price to sales: 0.20
Price to book: 0.63
Dividend yield: –